Home LiteratureArticle Details
PMID: 6992276 Published · ppublish English Comparative Study Journal Article Research Support, U.S. Gov't, P.H.S.

Survival of Escherichia coli host-vector systems in the mammalian intestine.

Science (New York, N.Y.) ·Vol. 209 ·No. 4454 ·1980-07-18 ·Pages 391-4

Levy SB, Marshall B, Rowse-Eagle D, Onderdonk A

Abstract

Survival in the mouse and human intestine of Escherichia coli host-vector systems used and proposed for recombinant DNA technology was assessed. There was no detectable survival of severely disabled E. coli K12 strain X1776 in mice or in human subjects 24 hours after ingestion. The same strain bearing the plasmid pBR322, however, was recovered from human subjects for 4 days in amounts of six organisms for every million ingested. Nondisabled E. coli K12 strain X1666, with or without pBR322, survived in 10(4)-fold greater numbers and for 2 days longer, with better recovery of the plasmid-containing derivative. Although the plasmid-bearing strains were recovered for longer periods, no intestinal colonization was noted. Despite the presence of pBR322 for a maximum of 6 days in the human intestine, there was no evidence that it was transferred from either bacterial host to endogenous aerobic fecal bacteria.

MeSH Terms
Animals DNA, Recombinant/metabolism Escherichia coli/physiology Humans Intestines/microbiology Mice Plasmids Species Specificity
Chemicals
DNA, Recombinant
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Levy S B
Marshall B
Rowse-Eagle D
Onderdonk A
Article Info
Journal
Science (New York, N.Y.)
Abbr.
Science
ISSN
0036-8075
Published
1980-07-18
Pages
391-4
Language
English
Region
United States
NLM ID
0404511
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com